Drugs.com - Clinical Trials

Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600

DEER PARK, Ill., March 14, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare...

Mar 18, 2025 - 01:11
 0
Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600
DEER PARK, Ill., March 14, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare...
Read More

Tags:

Previous Article

Zentalis Pharmaceuticals Presents Updated Azenosertib Clinical Data at the Socie...

Next Article

Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human ...

Related Posts

Icotrokinra Meets Primary Endpoint of Clinical Response in Ulcerative Colitis Study and Shows Potential to Transform the Treatment Paradigm for Patients

Icotrokinra Meets Primary Endpoint of Clinical Response...

Mar 10, 2025  0

Pila Pharma Announces XEN-D0501 Preclinical Proof-of-Concept Achieved In Cardiovascular Disease Study

Pila Pharma Announces XEN-D0501 Preclinical Proof-of-Co...

Feb 9, 2025  0

Pyxis Oncology Granted FDA Fast Track Designation for PYX-201 Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer

Pyxis Oncology Granted FDA Fast Track Designation for P...

Feb 27, 2025  0